`
`
`
`
`Trials@uspto.gov
`571-272-7822 Entered: August 16, 2017
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`v.
`
`ICOS CORPORATION,
`Patent Owner.
`____________
`
`Case IPR2017-00323
`Patent 6,943,166 B1
`_______________
`
`
`Before SHERIDAN K. SNEDDEN, SUSAN L. C. MITCHELL, and
`ZHENYU YANG, Administrative Patent Judges.
`
`
`YANG, Administrative Patent Judge.
`
`
`
`
`
`
`
`ORDER
`
`Termination of the Proceeding Due to Settlement after Institution
`35 U.S.C. § 317 and 37 C.F.R. § 42.72
`
`
`
`
`
`
`
`
`IPR2017-00323
`Patent 6,943,166 B1
`
`
`With our authorization, the parties filed a Joint Motion to Terminate
`
`this proceeding pursuant to 35 U.S.C. § 317(a). Paper 16. In addition,
`
`pursuant to 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c), the parties filed a
`
`true and correct copy of a settlement agreement (Ex. 1038), along with a
`
`Joint Motion to Keep Settlement Agreement as Business Confidential
`
`Information, to be kept separate from the publicly available patent files.
`
`Paper 17.
`
`Under 35 U.S.C. § 317(a), “[a]n inter partes review instituted under
`
`this chapter shall be terminated with respect to any petitioner upon the joint
`
`request of the petitioner and patent owner, unless the Office has decided the
`
`merits of the proceeding before the request for termination is filed.” In this
`
`case, the Board instituted trial on June 12, 2017. Paper 12. So far, Patent
`
`Owner has not filed its Patent Owner Response, and the Board has not
`
`decided the merits of the proceeding.
`
`Under 37 C.F.R. § 42.72, “[t]he Board may terminate a trial without
`
`rendering a final written decision, where appropriate, including . . . pursuant
`
`to a joint request under 35 U.S.C. 317(a).” After reviewing the Joint Motion
`
`to Terminate and the Settlement Agreement, we determine that it is
`
`appropriate to terminate the proceeding without rendering a final written
`
`decision. Therefore, the Joint Motion to Terminate is GRANTED.
`
`
`
`
`
`
`
`
`
`
`
`2
`
`
`
`IPR2017-00323
`Patent 6,943,166 B1
`
`
`Accordingly, it is
`
`ORDERED that the Joint Motion to Terminate is GRANTED and this
`
`proceeding is hereby TERMINATED; and
`
`FURTHER ORDERED that the Joint Motion to Keep Settlement
`
`Agreement as Business Confidential Information is GRANTED, and the
`
`settlement agreement will be kept separate from the patent files.
`
`
`PETITIONER:
`
`Steven W. Parmelee
`Michael T. Rosato
`Jad A. Mills
`WILSON SONSINI GOODRICH & ROSATI
`sparmelee@wsgr.com
`mrosato@wsgr.com
`jmills@wsgr.com
`
`PATENT OWNER:
`
`Mark J. Feldstein
`Joshua L. Goldberg
`Yieyie Yang
`Maureen D. Queler
`FINNEGAN, HENDERSON, FARABOW,
` GARRETT & DUNNER, LLP
`mark.feldstein@finnegan.com
`joshua.goldberg@finnegan.com
`yieyie.yang@finnegan.com
`maureen.queler@finnegan.com
`
`Mark J. Stewart
`Dan L. Wood
`ELI LILLY AND COMPANY
`stewart_mark@lilly.com
`wood_dan_l@lilly.com
`
`3
`
`
`
`
`
`